Relationship-driven banking tailored to support your business needs
See overview
Relationship-driven banking to help you achieve your financial goals
Relationship-driven expertise to plan, grow, and protect your wealth
The latest updates and articles from Arbuthnot Latham
Experts discussed the impact of regulations like the Building Safety Act 2022 on real estate, emphasising the need for proactive compliance to avoid legal issues and maintain property value and investment returns.
Experts highlight that interest rate hikes, global events, and demand for premium assets have shaped the BTL market.
In recent years, fluctuating interest rates have significantly influenced the real estate market, affecting everything from property values to investment returns. Understanding these impacts is crucial for investors, developers, and financial advisors navigating this volatile landscape.
Arbuthnot Commercial Asset Based Lending (ACABL) has supported remediation, groundworks and RC frames contractor for Statom Group
In our latest interview, we talk to Paul Langham, Senior Commercial Banking about client relationships.
In our latest interview, we speak to Gabriella Macari, Senior Investment Management about what financial wellbeing means to her.
When should a professional athlete start building a financial safety net? See what our experts say about financial planning for elite athletes looking for a more secure future.
A breakdown of the professional advisers that high profile individuals in sports, media and entertainment should curate to set themselves up for sustained wealth.
Arbuthnot Commercial ABL has once again demonstrated its commitment to enabling growth by providing a £7m funding package to support NVM Private Equity’s secondary buyout of MRO Solutions from Cairngorm Capital.
Arbuthnot Commercial Asset Based Lending (ACABL) has completed a flexible £4.5 million funding facility to support BIL Group's acquisition of Varley Castors (Varley).
Our dedicated investment research team has undertaken an in-depth exploration of the potential of GLP-1 medications.
In our latest interview, we talk to Nefeli Neophytou, Investment Research Analyst about her role within the Investment Management team.
